Biomira is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Biomira's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients.
Conference Call and Webcast
Biomira's management will hold a conference call beginning at 10:00 a.m. EDT today, September 12, 2007. To listen to a live webcast of the call, visit http://www.biomira.com. Biomira intends to make a recording of the webcast available on the Biomira website and via telephone replay. It is expected that the archive of the webcast will be available approximately 15 minutes after completion of the discussion and will be posted for 90 days. It is expected that a replay will be available by phone approximately one hour after completion of the discussion and will be accessible for 7 days. Access numbers for this replay are:
416-640-1917, passcode 21246399 followed by the pound sign or
877-289-8525, passcode 21246399 followed by the pound sign
Forward Looking Statements
In order to provide Biomira's investors with an understanding of its
current intentions and future prospects, this release contains statements
that are forward looking, including statements relating to the anticipated
benefits of the proposed reincorporation of Biomira from Canada to the
United States. These forward-looking state
|SOURCE Biomira Inc.|
Copyright©2007 PR Newswire.
All rights reserved